Risk factors for Visceral Leishmaniasis relapse in Immunocompetent patients following treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India

.post-filter-container .filters .dropdown-selected::after{--wpr-bg-ad8994d2-c7a5-4574-b913-fa01ca2a21e0: url('https://msfsouthasia.org/wp-content/uploads/2026/01/Vector5.png');}.main-filter-shortcode .filter-section .single-filter{--wpr-bg-434fa7e6-711b-4eb4-8de8-d2ea81076c26: url('https://msfsouthasia.org/wp-content/uploads/2026/01/Vector5.png');}.addtoany_list .a2a_button_copy_link{--wpr-bg-2cb5ff7e-570b-43fc-8700-15d4a65ab7c2: url('https://msfsouthasia.org/wp-content/themes/generatepress-child/');}.donation-bg-cont{--wpr-bg-398ae33b-2897-4eac-b4ec-d3b1b3be1ad4: url('https://msfsouthasia.org/wp-content/uploads/2026/02/Group-1410086062.png');}.rll-youtube-player .play{--wpr-bg-a2c97677-af4d-411f-8ce9-38e7ebc7eb7e: url('https://msfsouthasia.org/wp-content/plugins/wp-rocket/assets/img/youtube.png');}

In Focus › Reports

Reports

Published on January 1, 2014

Source: PLOS Medicine

Subscribe to newsletter

Reports

Latest Reports

An overview of recent operational activities, updates, and key outcomes.